Arthritis, and Rheumatic Diseases

Tags

ankylosing spondylitis, Anti-phospholipid antibody syndrome, Arthritis, Autoimmune Disease, biphosphonates, colitis, connective tissue disease, Crohn's disease, Enthesopathy, Granulomatous disease, Infectious Disease, inflammation, Monoclonal antibody, osteoarthritis, Osteonecrosis, osteoporosis, Psoriasis, Rheumatic diseases, rheumatoid arthritis, Rheumatology, Sarcoidosis, Scleroderma, Sjogren's Syndrome, Systemic Lupus, Systemic Sclerosis, ulcerative colitis

Regional problems

Temporomandibular joint disorders
Shoulder pain
Elbow pain
Wrist pain
Hand pain
Neck pain
Mid-Back pain
Back pain
Hip pain
Knee pain
Ankle pain
Foot pain
Fibromyalgia
Chronic Fatigue Syndrome
Reflex Sympathetic Dystrophy (RSD)
Neuropathy

Spondyloarthritis
Psoriatic arthritis
Colitis associated arthritis
Ankylosing Spondylitis
Reactive arthritis (Reiter’s Syndrome)

Infections and Arthritis
Viral Arthritis
Lyme disease
Rheumatic fever
Bacterial arthritis
Fungal arthritis
Gonococcal arthritis
Tuberculosis arthritis
Osteomyelitis

Bone diseases
Osteoporosis
Osteomalacia
Paget’s disease
Osteopetrosis
Osteogenesis Imperfecta
Ehlers-Danlos Syndrome
Parathyroid disorders
Osteonecrosis
Osteochondritis
Marfan Syndrome
Hypermobility

Crystal Induced Arthritis
Gout
Pseudo gout
Crystal arthritis

Systemic Diseases
Rheumatoid arthritis
Seronegative Arthritis
Palindromic Rheumatism
Sjögren’s syndrome
Undifferentiated connective tissue disease
Mixed connective tissue disease
Systemic Lupus
Drug Induced Lupus
Scleroderma (Systemic Sclerosis)
CREST Syndrome
Eosinophilic fasciitis
Adult-onset Still’s Disease
Anti phospholipid antibody syndrome

Vasculitis
Temporal arteritis
Polymyalgia Rheumatica
Takayasu’s arteritis
Polyarteritis Nodosa
Wegener’s granulomatosis
ANCA associated vasculitis
Microscopic polyangiitis
Allergic angiitis
Churg-Strauss syndrome
Henoch-Schönlein purpura
Urticarial Vaculitis
Leukocytoclastic Vasculitis
Cryoglobulinemia

Inflammatory Muscle Diseases
Polymyositis
Dermatomyositis
Inclusion-body myositis
Drug induced myopathy
Infectious myositis

Rheumatic diseases
Relapsing Polychondritis
Behçet’s Syndrome
Amyloidosis
Whipple’s disease
Sarcoidosis
Diabetic arthropathy
Immunodeficiency syndromes
Raynaud’s phenomenon

Pediatric Rheumatic Diseases
Juvenile Idiopathic Arthritis
Juvenile Spondyloarthritis
Juvenile connective tissue diseases
Dermatomyositis
Vasculitis
Scleroderma

Anti-Rheumatic Medications

Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
Aspirin (Ecotrin, Salicylic Acid) Bufferin
Celecoxib (Celebrex)
Diclofenac (Voltaren, Cataflam, Voltaren-XR)
Diflunisal (Dolobid)
Etodolac (Lodine)
Fenoprofen (Fenopron, Nalfron)
Flurbiprofen (Ansaid)
Ibuprofen (Advil, Motrin)
Indomethacin (Indocin)
Ketoprofen (Orudis, Oruvail)
Ketorolac (Toradol)
Meclofenamic acid (Meclomen)
Mefenamic acid (Ponstel)
Meloxicam (Mobic)
Nabumetone (Relafen)
Naproxen (Aleve, Anaprox, Naprosyn, Naprelan)
Oxaporozin (Daypro)
Piroxicam (Feldene)
Salsalate (Salflex, Disalcid, Trilisate)
Sulindac (Clinoril)

Steroids
Prednisone
Methylprednisolone
Hydrocortisone
Solumedrol
Celestone
Kenalog
Decadron
Aristospan
Depomedrol

Disease Modifying Drugs (DMARDs)
abatacept
adalimumab
azathioprine
Certolizumab pegol
chloroquine
Cyclosporin
Cyclophosphamide
D-penicillamine
etanercept
golimumab
gold salts
hydroxychloroquine
infliximab
leflunomide
methotrexate
minocycline
rituximab
sulfasalazine
Tocilizumab
Tofacitinib
Ustekinumab

Hypouricemic Drugs
Allopurinol
Colchicine
Uloric
Probenecid
Sulfinpyrazone

Osteoporosis Drugs
alendronate
risedronate
ibandronate
Pamidronate
zoledronic acid
raloxifene
denosumab
teriparatide

Rheumatology in pictures
Sternoclavicular joint swelling

Newest drug for treatment of osteoporosis!

Tags

alendronate, ostecoclast, osteoblast, romosozumab, sclerostin, teriparatide

Romosozumab is the newest agent for treatment of osteoporosis that appears to be far more effective than FOSAMAX (alendronate) and even more effective than Forteo (teriparatide) based on a recent study. It was not compared to the other monoclonal antibody on the market PROLIA possibly because they are both made by the same company.

This medication was given by injection every month and also every three months. A newer drug for osteoporosis has been long overdue and being an injectable given every month or every three months should improve compliance.

Hopefully this drug is priced similar to Prolia and not Forteo which is five times more expensive.

Most effective drug on the market today is still Forteo.

Prolia effective up to eight years for treatment of Osteoporosis!

Tags

Actonel, and Reclast, biphosphonates, bone loss, Boniva, DEXA, Fosamax, fracture, osteopenia, Prolia, t score

Prolia, an injectable drug used for treatment of osteoporosis, was shown to remain effective for up to eight years based on recent data presented.

This is certainly better than the current recommendations limiting the use of treatments with biphosphonatesg such as Fosamax, Actonel, Boniva, and Reclast to five years for lack of data.

In other words you could lose almost a third of your bone density and still have normal looking x-rays.!

Tags

Actonel, alendronate, bone loss, Boniva, denosumab, DEXA, Dual-Energy X-ray Absorptiometry, estrogen, Evista, Fosamax, Fosamax D) risedronate, ibandronate, osteoporosis, Prolia, raloxifene, Reclast, Zoledronic acid

Osteoporosis or Bone Loss can not be detected on routine X-rays unless you have lost 40 percent of your bone density.

In other words you could lose almost a third of your bone density and still have normal looking x-rays.

Therefore, if you want to know if you indeed have lost bone, you should obtain a DEXA examination.

DEXA or Dual-Energy X-ray Absorptiometry is a scanning technique using extremely low radiation exposure to determine bone density with Significant precision.